about
Comparative effectiveness research and its utility in In-clinic practiceConceptual and methodological issues in research on mindfulness and meditationThe Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsNo Survival Benefit for Patients with Treatment in Certified Breast Centers-A Population-based Evaluation of German Cancer Registry Data.Bisphosphonates and mortality in women with CKD and the presence or absence of cardiovascular disease.Distinguishing Selection Bias and Confounding Bias in Comparative Effectiveness Research.Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancerHospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.Harms, benefits, and the nature of interventions in pragmatic clinical trials.Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality.Conference report - samyukti 2013.Comparative effectiveness research in follicular lymphoma: current and future perspectives and challenges.Lessons from comparative effectiveness research methods development projects funded under the Recovery Act.The ARRA investment in CER: a description of the midstream evaluation and how the funds were allocated and CER priorities addressed.Literature review of visual representation of the results of benefit-risk assessments of medicinal products.Systemic lupus erythematous and clinical outcomes in peritoneal dialysis.Level of hospital care and outcome of gastric cancer: a population-based evaluation of the Munich Cancer Registry.Using nonrandomized studies to inform complex clinical decisions: the thorny issue of cranial radiation therapy for T-cell acute lymphoblastic leukemia.Comparing the Effectiveness of Methods to Measure Oxygen in Tissues for Prognosis and Treatment of Cancer.Cohort Profile: The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort.Analytical Methods for a Learning Health System: 1. Framing the Research Question.
P2860
Q26767184-2EAFC81A-60F0-4FAA-86EB-FC2F288E006CQ28085327-234AE190-F70A-4980-98D1-B6F81D2E1680Q28601505-B1E63858-51B8-47CB-A028-FC56C876FBB9Q30977803-24BEC2E5-A749-41AB-8160-54B5F2C1C07EQ33571790-47094CDB-02D2-41AE-854D-91322CCABED7Q33707304-8D5DDDB5-C4AA-4772-A359-0B950D835E4AQ33774527-CA2A544A-C9F3-4262-A32F-1EB998D5461CQ33992552-095A6B48-C8CC-4A99-819E-CD125319C458Q35677959-EA1B42E4-549F-4335-B0BC-96DA9EEB4DC5Q36117803-68A5666F-B08E-4A7C-AE7D-E40A57112F12Q37275615-E966291A-3D7D-49C4-A670-7141F8FA1BD6Q37476299-368157B2-491B-4DEF-B1C2-268C66EBE83CQ38171874-A2705A45-34D1-4616-B107-A50B7AB628B3Q38393292-DAE1C533-AC88-4EC2-87B6-A352DF3BA931Q38393299-58B1E561-7AC9-4136-A345-4090512744FFQ38621586-F6239BE0-3E04-460C-B31F-F7B0A389BC91Q41701045-80B1FABA-A395-4D01-BB82-7A44C69742C2Q50709702-F562FFB4-BF5C-492E-9EB1-0FF6EB3B6CF8Q51000445-D43C2AA1-10A2-4725-8FAD-CC87C635D1F0Q51470661-7707B872-BFCC-4FFE-9A6B-35779D5812B0Q52802234-AA1713CF-D239-4C0E-BBDA-00509AEF06ECQ55089263-5F555B51-4F80-40D8-AF5A-A0B49DB548C5
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Methods in comparative effectiveness research.
@ast
Methods in comparative effectiveness research.
@en
type
label
Methods in comparative effectiveness research.
@ast
Methods in comparative effectiveness research.
@en
prefLabel
Methods in comparative effectiveness research.
@ast
Methods in comparative effectiveness research.
@en
P2860
P356
P1476
Methods in comparative effectiveness research.
@en
P2093
Katrina Armstrong
P2860
P304
P356
10.1200/JCO.2012.42.2659
P407
P577
2012-10-15T00:00:00Z